The insights from SARS-CoV-2 antibodytreatment for future emerging infectious diseases

被引：1
|
作者：
Wang, Yeming [1 ,2 ,3 ,4 ,5 ]
Cao, Bin [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Natl Ctr Resp Med, Beijing, Peoples R China
[2] State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China
来源：
LANCET INFECTIOUS DISEASES | 2024年 / 24卷 / 01期
关键词：
D O I：
10.1016/S1473-3099(23)00454-1
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [1] Recent Insights into Emerging Coronavirus: SARS-CoV-2
    Shang, Zifang
    Chan, Siew Yin
    Liu, William J.
    Li, Peng
    Huang, Wei
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1369 - 1388
  • [2] Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus
    Ipekci, Aziz Mert
    Buitrago-Garcia, Diana
    Meili, Kaspar Walter
    Krauer, Fabienne
    Prajapati, Nirmala
    Thapa, Shabnam
    Wildisen, Lea
    Araujo-Chaveron, Lucia
    Baumann, Lukas
    Shah, Sanam
    Whiteley, Tessa
    Solis-Garcia, Gonzalo
    Tsotra, Foteini
    Zhelyazkov, Ivan
    Imeri, Hira
    Low, Nicola
    Counotte, Michel Jacques
    BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [3] Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus
    Aziz Mert Ipekci
    Diana Buitrago-Garcia
    Kaspar Walter Meili
    Fabienne Krauer
    Nirmala Prajapati
    Shabnam Thapa
    Lea Wildisen
    Lucia Araujo-Chaveron
    Lukas Baumann
    Sanam Shah
    Tessa Whiteley
    Gonzalo Solís-García
    Foteini Tsotra
    Ivan Zhelyazkov
    Hira Imeri
    Nicola Low
    Michel Jacques Counotte
    BMC Medical Research Methodology, 21
  • [4] Insights from SARS-CoV-2 sequences
    Martin, Michael A.
    VanInsberghe, David
    Koelle, Katia
    SCIENCE, 2021, 371 (6528) : 466 - 467
  • [5] Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Cheng, Qi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 62 - 83
  • [6] Control of SARS-CoV-2 infection in skilled nursing facilities in Detroit, Michigan: a model for emerging infectious diseases
    Joshi, Seema
    Arshad, Samia
    Lindsay, Abigail
    Heinonen, Jessica
    Misikir, Helina
    Zervos, John
    Prentiss, Tyler
    Verkler, Jelena
    Numi, Mariia
    Czander, Bonnie
    David, Randy E.
    Mossing, Michael
    Kilgore, Paul E.
    Rehman, Najibah
    Zervos, Marcus
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024, 45 (08) : 1012 - 1014
  • [7] SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Murugan, Avaniyapuram Kannan
    Alzahrani, Ali S.
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 6191 - 6221
  • [8] SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects
    Li, Shiqin
    Li, Sijia
    Disoma, Cyrollah
    Zheng, Rong
    Zhou, Mei
    Razzaq, Aroona
    Liu, Pinjia
    Zhou, Yuzheng
    Dong, Zijun
    Du, Ashuai
    Peng, Jian
    Hu, Liqiang
    Huang, Jufang
    Feng, Pinghui
    Jiang, Taijiao
    Xia, Zanxian
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (02)
  • [9] The emerging plasticity of SARS-CoV-2
    McCormick, Kevin D.
    Jacobs, Jana L.
    Mellors, John W.
    SCIENCE, 2021, 371 (6536) : 1306 - 1308
  • [10] SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments
    Adesokan, Adedapo
    Obeid, Mohammad A.
    Lawal, Aisha F.
    THERAPEUTIC DELIVERY, 2022, 13 (03) : 187 - 203
12345